- Home
- NXST vs PCVX Comparison
NXST vs PCVX Comparison
Compare NXST & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NXST | PCVX |
|---|---|---|
| Founded | 1996 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Broadcasting | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 6.1B |
| IPO Year | 2003 | 2020 |
Fundamental Metrics
Financial Performance| Metric | NXST | PCVX |
|---|---|---|
| Price | $214.50 | $55.22 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 7 |
| Target Price | ★ $220.33 | $97.67 |
| AVG Volume (30 Days) | 334.6K | ★ 1.6M |
| Earning Date | 02-26-2026 | 02-24-2026 |
| Dividend Yield | ★ 3.48% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 16.23 | N/A |
| Revenue | ★ $5,147,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $10.29 | N/A |
| P/E Ratio | $13.17 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $141.66 | $27.66 |
| 52 Week High | $223.36 | $91.77 |
Technical Indicators
Market Signals| Indicator | NXST | PCVX |
|---|---|---|
| Relative Strength Index (RSI) | 57.51 | 62.39 |
| Support Level | $201.35 | $53.28 |
| Resistance Level | $213.75 | $58.95 |
| Average True Range (ATR) | 6.11 | 3.34 |
| MACD | -0.35 | 0.37 |
| Stochastic Oscillator | 73.03 | 72.66 |
Price Performance
Historical ComparisonAbout NXST Nexstar Media Group Inc.
Nexstar is the largest television station owner-operator in the United States with over 200 stations in 116 markets, reaching 220 million people. Of its 200 stations, 155 are affiliated with the four national broadcast networks: CBS, Fox, NBC, and ABC. Pending approval, Nexstar's merger with Tegna would bring Nexstar's station total to 259 in 133 markets, reaching 80% of the US population. Nexstar also owns NewsNation (formerly WGN), a cable news network, 75% of the fifth national broadcaster, the CW, and a 31% stake in Food Network and Cooking Channel.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.